Page 72 - IJB-7-2
P. 72

RESEARCH ARTICLE

           Bioinks for 3D Bioprinting: A Scientometric Analysis of

           Two Decades of Progress


           Sara Cristina Pedroza-González , Marisela Rodriguez-Salvador , Baruc Emet Pérez-Benítez ,
                                            1,2
                                                                             3
                                                                                                          3
           Mario Moisés Alvarez *, Grissel Trujillo-de Santiago *
                                                                  1,2
                                 1,4
           1 Centro de Biotecnología-FEMSA, Tecnologico de Monterrey, Monterrey, NL, 64849, Mexico
           2 Departamento de Ingeniería Mecatrónica y Eléctrica, Escuela de Ingeniería y Ciencias, Tecnologico de Monterrey,
           Monterrey, NL, 64849, Mexico
           3 Tecnologico de Monterrey, Escuela de Ingenieria y Ciencias, Monterrey, NL, 64849, Mexico
           4 Departamento de Bioingeniería, Escuela de Ingeniería y Ciencias, Tecnologico de Monterrey, Monterrey, NL, Mexico
           64849

           Abstract:  This scientometric analysis of 393 original papers published from January 2000  to June 2019 describes the
           development and use of bioinks for 3D bioprinting. The main trends for bioink applications and the primary considerations
           guiding the selection and design of current bioink components (i.e., cell types, hydrogels, and additives) were reviewed. The
           cost, availability, practicality, and basic biological considerations (e.g., cytocompatibility and cell attachment) are the most
           popular parameters guiding bioink use and development. Today, extrusion bioprinting is the most widely used bioprinting
           technique. The most reported use of bioinks is the generic characterization of bioink formulations or bioprinting technologies
           (32%), followed by cartilage bioprinting applications (16%). Similarly, the cell-type choice is mostly generic, as cells are
           typically used as models to assess bioink formulations or new bioprinting methodologies rather than to fabricate specific
           tissues. The cell-binding motif arginine-glycine-aspartate is the most common bioink additive. Many articles reported the
           development of advanced functional bioinks for specific biomedical applications; however, most bioinks remain the basic
           compositions that meet the simple criteria: Manufacturability and essential biological performance. Alginate and gelatin
           methacryloyl are the most popular hydrogels that meet these criteria. Our analysis suggests that present-day bioinks still
           represent a stage of emergence of bioprinting technology.

           Keywords:  Bioinks; Bioprinting; Scientometrics; Tissue engineering; Organ

           *Correspondence to: Grissel Trujillo-de Santiago, Centro de Biotecnología-FEMSA, Tecnologico de Monterrey, Monterrey, NL, Mexico 64849;
           grissel@tec.mx; Mario Moisés Alvarez, Centro de Biotecnología-FEMSA, Tecnologico de Monterrey, Monterrey, NL, 64849, Mexico;
           mario.alvarez@tec.mx
           Received: January 4, 2021; Accepted: February 4, 2021; Published Online: April 20, 2021

           Citation: Pedroza-González  SC, Rodriguez-Salvador  M, Pérez-Benítez  BE,  et  al., 2021, Bioinks  for 3D Bioprinting: A
           Scientometric Analysis of Two Decades of Progress.  Int J Bioprint, 7(2):337. http://doi.org/10.18063/ijb.v7i2.337

           1. Introduction                                     platforms  for drug screening, drug development,  and
                                                               personalized therapies. [5,7]
           Bioprinting  is a  growing technology [1,2]  that  promises   The goal of 3D bioprinting is to manufacture living
           a  future  in  which  patients  in  need  will  have  access  to   volumetric constructs by depositing a material containing
           3D-printed tissues and organs that  can substitute  those   living cells (i.e., a bioink) in a layer-by-layer fashion [6,8,9] .
           lost or damaged [3,4] . Bioprinting has already  enabled   A bioink is composed of living cells that may contain
           the fabrication of small units of tissues and organs that   other  elements,  such  as  a  water-rich  polymer  network
           recapitulate some functions of their native counterparts [5,6] .   and functional  additives  (i.e., molecules  or particles)
           These mini-tissues and organoids have also proven   associated  with  the  intended  application .  The  bioink
                                                                                                  [10]
           useful as in vitro models for basic research and as testing   is so central to the concept of bioprinting that it is the
           © 2021 Pedroza-González, et al. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0
           International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting all non-commercial use, distribution, and reproduction in any medium,
           provided the original work is properly cited.
           68
   67   68   69   70   71   72   73   74   75   76   77